Yang X - Search Results

1

Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.

Yu P, Yu H, Guo C, Cui Z, Chen X, Yin Q, Zhang P, Yang X, Cui H, Li Y. Yu P, et al. Among authors: yang x. Acta Biomater. 2015 Mar;14:115-24. doi: 10.1016/j.actbio.2014.12.001. Epub 2014 Dec 9. Acta Biomater. 2015. PMID: 25498306

2

Dual temperature/pH-sensitive drug delivery of poly(N-isopropylacrylamide-co-acrylic acid) nanogels conjugated with doxorubicin for potential application in tumor hyperthermia therapy.

Xiong W, Wang W, Wang Y, Zhao Y, Chen H, Xu H, Yang X. Xiong W, et al. Among authors: yang x. Colloids Surf B Biointerfaces. 2011 Jun 1;84(2):447-53. doi: 10.1016/j.colsurfb.2011.01.040. Epub 2011 Feb 2. Colloids Surf B Biointerfaces. 2011. PMID: 21330116

3

Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles.

Xiao L, Xiong X, Sun X, Zhu Y, Yang H, Chen H, Gan L, Xu H, Yang X. Xiao L, et al. Among authors: yang h, yang x. Biomaterials. 2011 Aug;32(22):5148-57. doi: 10.1016/j.biomaterials.2011.03.071. Epub 2011 May 4. Biomaterials. 2011. PMID: 21546083

4

Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.

Guo Y, Chu M, Tan S, Zhao S, Liu H, Otieno BO, Yang X, Xu C, Zhang Z. Guo Y, et al. Among authors: yang x. Mol Pharm. 2014 Jan 6;11(1):59-70. doi: 10.1021/mp400514t. Epub 2013 Nov 21. Mol Pharm. 2014. PMID: 24229050

5

Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.

Zhao X, Chen Q, Liu W, Li Y, Tang H, Liu X, Yang X. Zhao X, et al. Among authors: yang x. Int J Nanomedicine. 2014 Dec 30;10:257-70. doi: 10.2147/IJN.S73322. eCollection 2015. Int J Nanomedicine. 2014. PMID: 25565818 Free PMC article.

6

Redox-Sensitive Hydroxyethyl Starch-Doxorubicin Conjugate for Tumor Targeted Drug Delivery.

Hu H, Li Y, Zhou Q, Ao Y, Yu C, Wan Y, Xu H, Li Z, Yang X. Hu H, et al. Among authors: yang x. ACS Appl Mater Interfaces. 2016 Nov 16;8(45):30833-30844. doi: 10.1021/acsami.6b11932. Epub 2016 Nov 7. ACS Appl Mater Interfaces. 2016. PMID: 27791359

7

Multifunctional hybrid micelles with tunable active targeting and acid/phosphatase-stimulated drug release for enhanced tumor suppression.

Liu X, Li Y, Tan X, Rao R, Ren Y, Liu L, Yang X, Liu W. Liu X, et al. Among authors: yang x. Biomaterials. 2018 Mar;157:136-148. doi: 10.1016/j.biomaterials.2017.12.006. Epub 2017 Dec 11. Biomaterials. 2018. PMID: 29268144

8

Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.

Hakeem A, Zahid F, Zhan G, Yi P, Yang H, Gan L, Yang X. Hakeem A, et al. Among authors: yang h, yang x. Int J Nanomedicine. 2018 Feb 19;13:1029-1040. doi: 10.2147/IJN.S146955. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29497295 Free PMC article.

9

Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers.

Huang W, Lang Y, Hakeem A, Lei Y, Gan L, Yang X. Huang W, et al. Among authors: yang x. Int J Nanomedicine. 2018 Mar 21;13:1723-1736. doi: 10.2147/IJN.S157368. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29606866 Free PMC article.

10

D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.

Tan X, Fang Y, Ren Y, Li Y, Wu P, Yang X, Liu W. Tan X, et al. Among authors: yang x. Int J Nanomedicine. 2019 Feb 18;14:1255-1268. doi: 10.2147/IJN.S191858. eCollection 2019. Int J Nanomedicine. 2019. PMID: 30863058 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75,641 results

Search Page

Filters